文献速递先天性心脏病外科

高危患儿延迟Norwood手术结局:是否应重新审视一期Norwood的教条?

Outcomes of Delayed Norwood Operation in High-Risk Patients-Time to Reconsider the Dogma of a Primary Norwood Operation?
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2026-01-01

该单中心回顾性研究分析2019至2024年20例具有多重危险因素的左心发育不良综合征/变异患儿,先接受双侧肺动脉环缩(bPAB),再行延迟Norwood(DN)手术。DN中位年龄36天,手术生存率75%,术后乳酸清除及血管活性药物评分改善,无ECMO支持者脑近红外光谱值提升。作者认为高危队列DN结局可与低危一期Norwood相当,bPAB后约4-6周行DN或可改善生存并减少再干预。

要点

  • 高危左心发育不良综合征患儿可先行bPAB稳定病情,再延迟Norwood手术
  • bPAB后4周内行DN者未需肺动脉再干预,DN中位年龄36天,手术生存率75%
  • 术后48小时血管活性药物评分中位下降47%,无ECMO者脑氧饱和度改善

核心结论

  • 在高危患儿队列中,先bPAB后延迟Norwood手术取得了与低危患儿一期Norwood手术相当的手术结局。
  • bPAB后约4-6周行DN可能改善高危患者生存率并减少外科或导管再干预。

研究设计与样本

  • 单中心回顾性研究,纳入2019至2024年20例连续接受bPAB后延迟Norwood手术的左心发育不良综合征/变异且伴多重危险因素患者。

主要发现

  • bPAB中位年龄2.5天(IQR 2-4),DN中位年龄36天(IQR 29-79),手术生存率75%。
  • bPAB后4周内行DN的患者未需任何肺动脉再干预。
  • 术后中位乳酸清除时间8小时(IQR 5-18),中位血管活性药物评分48小时内下降47%。
  • 未接受术后ECMO支持者脑近红外光谱值在0、12、36小时分别从53%改善至58%和63%。

关键数值与推荐

  • 术前危险因素包括早产35%、低出生体重<2.5 kg 25%、非心脏合并症25%、遗传综合征50%、术前心源性休克35%、限制性房间隔25%。

临床怎么用

  • 对具有多重危险因素的高危左心发育不良综合征患儿,可考虑先bPAB稳定病情,再于bPAB后约4-6周行延迟Norwood手术。

局限性

  • 单中心回顾性设计,样本量20例,无对照组,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The delayed Norwood (DN) approach, preceded by bilateral pulmonary artery banding (bPAB), has emerged as a strategy to improve outcomes in high-risk infants by addressing neonatal haemodynamic instability and organ immaturity. METHODS: This single-centre, retrospective study analysed 20 consecutive patients with hypoplastic left heart syndrome/variants and multiple risk factors who underwent a DN operation following bPAB between 2019 and 2024. RESULTS: Bilateral pulmonary artery banding was performed at a median age of 2.5 days (interquartile range [IQR]: 2-4). Preoperative risk factors included prematurity (35%), low birth weight <2.5 kg (25%), non-cardiac comorbidities (25%), genetic syndromes (50%), preoperative cardiogenic shock (35%), and restrictive atrial septum (25%). The median age at DN was 36 days (IQR: 29-79), with an operative survival rate of 75%. Patients who underwent the DN within 4 weeks of bPAB did not require any pulmonary artery (PA) reinterventions. Median lactate clearance time was 8 hours (IQR: 5-18), and the median vasoactive inotropic score decreased by 47% within 48 hours postoperatively. Cerebral near-infrared spectroscopy values improved in patients without postoperative extracorporeal membrane oxygenation (ECMO) support from 53% to 58% and 63% at 0, 12, and 36 hours, respectively. CONCLUSIONS: The DN approach, preceded by initial bPAB in a high-risk patient cohort, achieved surgical outcomes comparable to those of lower-risk patients undergoing primary Norwood operation. A DN procedure around 4-6 weeks of following bPAB may improve survival rates in high-risk patients with a reduction in surgical or catheter-based reinterventions.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ozturk M, Selcuk A, Tongut A, et al. Outcomes of Delayed Norwood Operation in High-Risk Patients-Time to Reconsider the Dogma of a Primary Norwood Operation? Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42663575. doi:10.1093/icvts/ivag218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。